The development of structure-switching electrochemical, aptamer-based sensors over the past ~10 years has lead to a variety of reagentless sensors capable of analytical detection in a range of sample matrices. The crux of this methodology is the coupling of target-induced conformation changes of a redox-labeled aptamer with electrochemical detection of the resulting altered charge transfer rate between the redox molecule and electrode surface. Using aptamer recognition expands the highly sensitive detection ability of electrochemistry to a range of previously inaccessible analytes. In this review, we focus on the methods of sensor fabrication and how sensor signaling is affected by fabrication parameters. We then discuss the fundamentals of sensor signaling, as well as quantitative characterization of the analytical performance of electrochemical, aptamer-based sensors. Using illustrative examples, we highlight recent advances in the field that impact important areas of analytical chemistry. Finally, we discuss challenges and prospects for this class of sensors.
Aptamers have emerged as promising biorecognition elements in the development of electrochemical-based sensors. Aptamers, short oligonucleotides of DNA or RNA selected in vitro to bind a specific target, boast comparable binding affinities to antibodies, but possess superior chemical and biochemical stabilities. In addition, they require relatively simple synthesis protocols compared to the in vivo development of antibodies. Coupling the specific recognition abilities of aptamers with the selective and sensitive detection abilities of electrochemical signal transduction enables an almost unlimited number of strategies for generating biosensor architectures. Here we present a critical review of electrochemical sensing strategies employing aptamers through a presentation of the various signal transduction mechanisms employed. We find that, while there are numerous examples of aptamer-based sensors, the penetration of these platforms beyond the academic laboratory and proof-of-concept remains limited. We believe that aptamers will continue to be a focus in the development electrochemical sensors, although the limited number of proven aptamers hinders the progress of electrochemical, aptamer-based sensors from impacting fields beyond the electrochemical laboratory. However, considering the historical success of electrochemical-based sensors as well as the promise of selecting aptamers for virtually any target, we believe the future is bright for aptamers in electroanalysis and beyond.Electrochemistry has maintained a strong presence in the field of chemical and biological sensors. 1-6 This is because electrochemical readout mechanisms can provide a selective way to quantify the interaction between a recognition element and a target analyte. One of the most prolific examples of an electrochemical sensor is the glucose sensor, which incorporates an immobilized enzyme as a specific biorecognition element. The enzymatic conversion of glucose is monitored amperometrically using a wide variety of detection schemes (for a review see ref. 4). Regardless of the scheme, biology provides the specific recognition abilities of this sensing platform because the enzyme, glucose oxidase for example, has evolved to react only with glucose. Electrochemical readout provides the selective measurement capabilities. The known redox potential of the product or mediator and the relatively few electrochemically active interferents in biological medium allow this detection to be performed directly in undiluted human blood. 4 The numerous examples of enzyme-based glucose sensors demonstrate the utility of coupling specific recognition with electrochemical signal transduction.In addition to the enzyme-based sensor described above, electrochemical detection has seen widespread use in endless examples of chemical and biosensors. For example, electrochemical readout is utilized in the development of enzyme-linked immunosorbent assays or ELISAs. In this class of sensors, the specificity of antibody-antigen interactions provides target recognition, ...
The utility of stochastic single-molecule
detection using protein
nanopores has found widespread application in bioanalytical sensing
as a result of the inherent signal amplification of the resistive
pulse method. Integration of protein nanopores with high-resolution
scanning ion conductance microscopy (SICM) extends the utility of
SICM by enabling selective chemical imaging of specific target molecules,
while simultaneously providing topographical information about the net ion flux through a pore
under a concentration gradient. In this study, we describe the development
of a bioinspired scanning ion conductance microscopy (bio-SICM) approach
that couples the imaging ability of SICM with the sensitivity and
chemical selectivity of protein channels to perform simultaneous pore
imaging and specific molecule mapping. To establish the framework
of the bio-SICM platform, we utilize the well-studied protein channel
α-hemolysin (αHL) to map the presence of β-cyclodextrin
(βCD) at a substrate pore opening. We demonstrate concurrent
pore and specific molecule imaging by raster scanning an αHL-based
probe over a glass membrane containing a single 25-μm-diameter
glass pore while recording the lateral positions of the probe and
channel activity via ionic current. We use the average channel current
to create a conductance image and the raw current–time traces
to determine spatial localization of βCD. With further optimization,
we believe that the bio-SICM platform will provide a powerful analytical
methodology that is generalizable, and thus offers significant utility
in a myriad of bioanalytical applications.
The
utility of biological nanopores for the development of sensors
has become a growing area of interest in analytical chemistry. Their
emerging use in chemical analysis is a result of several ideal characteristics.
First, they provide reproducible control over nanoscale pore sizes
with an atomic level of precision. Second, they are amenable to resistive-pulse
type measurement systems when embedded into an artificial lipid bilayer.
A single binding event causes a change in the flow of millions of
ions across the membrane per second that is readily measured as a
change in current with excellent signal-to-noise ratio. To date, ion
channel-based biosensors have been limited to well-behaved proteins.
Most demonstrations of using ion channels as sensors have been limited
to proteins that remain in the open, conducting state, unless occupied
by an analyte of interest. Furthermore, these proteins are nonspecific,
requiring chemical, biochemical, or genetic manipulations to impart
chemical specificity. Here, we report on the use of the pore-forming
abilities of heat shock cognate 70 (Hsc70) to quantify a specific
analyte. Hsc70 reconstitutes into phospholipid membranes and opens
to form multiple conductance states specifically in the presence of
ATP. We introduce the measurement of “charge flux” to
characterize the ATP-regulated multiconductance nature of Hsc70, which
enables sensitive quantification of ATP (100 μM–4 mM).
We believe that monitoring protein-induced charge flux across a bilayer
membrane represents a universal method for quantitatively monitoring
ion-channel activity. This measurement has the potential to broaden
the library of usable proteins in the development of nanopore-based
biosensors.
The development of a hybrid, tri-catalytic architecture is demonstrated by immobilizing MWCNTs, TEMPO-modified linear poly(ethylenimine) and oxalate decarboxylase on an electrode to enable enhanced electrochemical oxidation of glycerol. This immobilized, hybrid catalytic motif results in a synergistic 3.3-fold enhancement of glycerol oxidation and collects up to 14 electrons per molecule of glycerol.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.